Medical economics

Financial risks posed by unproven stem cell interventions in Japan

The research group led by Professor Misao Fujita conducted a study to estimate the total amount the Japanese government would refund if a patient received unproven cell interventions and applied for a medical expense deduction.

Medical economics

Ethicists appeal for a more global COVID-19 care model

The omicron subvariant BA.2 is causing a new tide of COVID-19 cases in the United States and regions abroad. Meanwhile the effort to vaccinate 70% of global populations reportedly is losing momentum.

Diseases, Conditions, Syndromes

Providing a potential treatment option to infants where there is none

A little over 1% of babies born in the U.S. in 2020 fell under the category of very low birthweight, meaning they weighed less than 1,500 grams at birth, or less than 3 pounds, 4 ounces. And considering that the Centers ...

page 40 from 40